Skip to content
10-Q

Quarterly Report

MAZE THERAPEUTICS, INC. MAZE

0000950170-25-107306

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 43.85M sh
Shares Diluted Q2 2025 · Jun 30, 2025 43.8M sh
Shares Diluted Q2 2025 · Jun 30, 2025 36.25M sh
Shares Diluted Q2 2025 · Jun 30, 2024 4.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 3.27M sh
Capex Q2 2025 · Jun 30, 2025 $692K
Capex Q2 2025 · Jun 30, 2024 $439K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$59.57M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $121.61M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $264.54M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $196.81M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $175.07M
Stockholders Equity Q2 2025 · Jun 30, 2025 $262.24M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$311.18M
Current Liabilities Q2 2025 · Jun 30, 2025 $19.9M
Current Liabilities Q2 2025 · Dec 31, 2024 $20.67M
Total Liabilities Q2 2025 · Jun 30, 2025 $41.28M
Total Liabilities Q2 2025 · Dec 31, 2024 $43.64M
Current Assets Q2 2025 · Jun 30, 2025 $271.15M
Current Assets Q2 2025 · Dec 31, 2024 $201.67M
Total Assets Q2 2025 · Jun 30, 2025 $303.52M
Total Assets Q2 2025 · Dec 31, 2024 $240.54M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.77
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.83
Eps Diluted Q2 2025 · Jun 30, 2024 $3.22
Eps Diluted Q2 2025 · Jun 30, 2024 $3.18
Eps Basic Q2 2025 · Jun 30, 2025 −$0.77
Eps Basic Q2 2025 · Jun 30, 2025 −$1.83
Eps Basic Q2 2025 · Jun 30, 2024 $5.92
Eps Basic Q2 2025 · Jun 30, 2024 $4.54
Sga Expense Q2 2025 · Jun 30, 2025 $8.37M
Sga Expense Q2 2025 · Jun 30, 2025 $16.19M
Sga Expense Q2 2025 · Jun 30, 2024 $5.9M
Sga Expense Q2 2025 · Jun 30, 2024 $12.04M
Rd Expense Q2 2025 · Jun 30, 2025 $28.11M
Rd Expense Q2 2025 · Jun 30, 2025 $55.69M
Rd Expense Q2 2025 · Jun 30, 2024 $19.55M
Rd Expense Q2 2025 · Jun 30, 2024 $41.42M
Net Income Q2 2025 · Jun 30, 2025 −$33.68M
Net Income Q2 2025 · Jun 30, 2025 −$66.47M
Net Income Q2 2025 · Mar 31, 2025 −$32.79M
Net Income Q2 2025 · Jun 30, 2024 $139.06M
Net Income Q2 2025 · Jun 30, 2024 $106.56M
Net Income Q2 2025 · Mar 31, 2024 −$32.49M
Operating Income Q2 2025 · Jun 30, 2025 −$36.47M
Operating Income Q2 2025 · Jun 30, 2025 −$71.88M
Operating Income Q2 2025 · Jun 30, 2024 $139.56M
Operating Income Q2 2025 · Jun 30, 2024 $111.54M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 $165M
Revenue Q2 2025 · Jun 30, 2024 $165M